One In Ten Adults Diabetic By 2030 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

One In Ten Adults Diabetic By 2030



World Diabetes Day on Nov. 14, 2011, saw the release of the International Diabetic Federation’s (IDF) fifth edition of the Diabetes Atlas, which produced some staggering statistics for future escalation of the disease. According to a press release, figures indicate that the number of people living with the disease could rise from 366 million in 2011 to 552 million by 2030, if preventative measures are not considered. To put these numbers into perspective, such a dramatic rise equates to three new cases every 10 seconds, or almost 10 million each year.

“In every country and in every community worldwide, we are losing the battle against this cruel and deadly disease,” Jean Claude Mbanya, president of IDF, said in a press statement. “We want World Diabetes Day 2011 to bring these alarming diabetes facts into the global spotlight. We demand that public and world leaders act on diabetes now.”

Low- and middle-income countries have been brought into the spotlight this year—80% of people with diabetes live in such countries. In Africa, figures indicate that diabetes cases could increase by as much as 90% by 2030, and that 78% of diabetics in Africa are undiagnosed. However, the US, with an estimated 23.7 million, has the highest number of people living with diabetes, which, sadly, goes hand-in-hand with the highest number of deaths per year at 180,000. If you think the headline is shocking, one in ten adults in North America have diabetes today. Europe fairs little better with children at high risk; the findings of the report show that 116,000 children in Europe have type 1 diabetes with 18,000 new cases in 2011—the highest number in all IDF regions.

In September, 193 Heads of State and government met at the UN High Level Meeting in New York to agree on a Political Declaration on non-communicable diseases (NCDs) such as diabetes, which marks a major milestone. “World leaders have recognised the magnitude and impact of these diseases and the urgent need for action. In some key areas we wanted stronger commitments and targets but the Declaration will accelerate international progress on diabetes and NCDs, saving millions of people from preventable death and disability,” said Ann Keeling, IDF CEO and chair of the NCD Alliance.

World Diabetes Day was created in 1991 by IDF and WHO and is celebrated every year on Nov. 14. It aims to address the escalating health threat of diabetes by increasing awareness of the disease. This year is the third of a five-year campaign that will focus on diabetes education and prevention programmes. The initiative is also supported by the European Medicines Agency, which plays a crucial role in the authorisation of medicines to treat diabetes in Europe and works closely with the Insulin Dependent Diabetes Trust and the International Diabetes Federation.

From an industry point of view, according to an IMS Health report, the total global audited market for antidiabetics in 2010 was $34.4 billion, ranked fourth in the top 20 global therapeutic classes. The 12th Annual Pharm Exec 50 reported that antidiabetics also came fourth in the top 20 therapeutic classes by spending at $16.9 billion.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
44%
Facility/environment problems
0%
Process development problems
11%
Production equipment downtime
11%
Raw material supply problems
11%
Regulatory restrictions
0%
Business decisions to limit production
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Patent Settlements Become More Risky
Praise and Perils for Biotechnology Patent Policy
Risk-Mitigation Strategies in Drug Manufacturing for Emerging Markets
Quality Focus: Ensuring Raw Material Transparency
Advertising of Prescription Drugs  Keeping it Honest and Balanced

Click here